GHTC Breakthroughs Blog

Research Roundup: New TB drug regimen for drug-resistant infections, Gates Foundation to fund study for coronavirus cure, and long-acting treatment for HIV

PATH/Doune Porter

March 8, 2020

Research Roundup: New TB drug regimen for drug-resistant infections, Gates Foundation to fund study for coronavirus cure, and long-acting treatment for HIV

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn

GHTC

Research Roundup: WHO launches digital EML, coronavirus vaccine ready for testing, and coronavirus treatment study underway

PATH/Matthew Dakin

March 1, 2020

Research Roundup: WHO launches digital EML, coronavirus vaccine ready for testing, and coronavirus treatment study underway

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn

GHTC

Research Roundup: Ebola vaccine licensed in five African countries, Sanofi & HHS to develop COVID-19 vaccine, and digital AMR platform in Zambia

PATH/Matthew Dakin

February 23, 2020

Research Roundup: Ebola vaccine licensed in five African countries, Sanofi & HHS to develop COVID-19 vaccine, and digital AMR platform in Zambia

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn

GHTC

Research Roundup: Ebola outbreak wanes, remdesivir prevents MERS coronavirus disease in monkeys, and Trump's budget would cut global health programs

PATH/Patrick McKern

February 16, 2020

Research Roundup: Ebola outbreak wanes, remdesivir prevents MERS coronavirus disease in monkeys, and Trump's budget would cut global health programs

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn

GHTC

#HealthPolicyValentines for global health research

GHTC

February 14, 2020

#HealthPolicyValentines for global health research

To celebrate Valentine’s Day, GHTC staff embraced our health policy wonkiness by participating in the time-honored beltway tradition, #HealthPolicyValentines, to share our passion for global health R&D. Check out our favorites.

Marissa Chmiola GHTC

3 takeaways from the WHO Executive Board meeting

WHO

February 13, 2020

3 takeaways from the WHO Executive Board meeting

With the global health emergency of the novel coronavirus looming large, last week the global health community gathered in Geneva to kick off the World Health Organization (WHO) Executive Board (EB) meeting. GHTC was on the scene following the official agenda and delivering statements. Here are our top three takeaways from this year’s EB.

Philip Kenol GHTC

Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

From the Breakthroughs Blog: Page #5

Research Roundup: New TB drug regimen for drug-resistant infections, Gates Foundation to fund study for coronavirus cure, and long-acting treatment for HIV

Research Roundup: WHO launches digital EML, coronavirus vaccine ready for testing, and coronavirus treatment study underway

Research Roundup: Ebola vaccine licensed in five African countries, Sanofi & HHS to develop COVID-19 vaccine, and digital AMR platform in Zambia

Research Roundup: Ebola outbreak wanes, remdesivir prevents MERS coronavirus disease in monkeys, and Trump's budget would cut global health programs

#HealthPolicyValentines for global health research

3 takeaways from the WHO Executive Board meeting